SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jul 7, 2026

XERS

Xeris Biopharma Holdings, Inc.
BEARISH
Impact 4/10
Horizondays Processed4mo ago
Insider cluster: 3 insiders, $1.0M total
Actionable Insight ▼ Bearish

Three Xeris Biopharma insiders (C-suite/top officers) sold a total of ~$1.0M in stock over a 7-day window ending July 6, 2026, including a $723K sale by the CEO. The selling occurred near $8.03-$8.50, just off the stock's recent highs. While the dollar amount is modest relative to the $1.4B market cap (~0.07%), the cluster includes the CEO's largest single sale in the cluster and coincides with recent positive insider selling patterns (4 sales totaling $1.2M in the prior 30 days). No 10b5-1 pattern is evident from the data provided, and the cluster lacks an offsetting buy direction.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$8.67
T+0 close · Jul 7, 2026 · via day close
Latest settled
+6.69%
T+60 · $9.25
Vs SPY
+4.20%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 8 $8.67entry
  2. T+1 · 4mo ago −0.58%α −1.42% · $8.62
  3. T+5 · 4mo ago +0.35%α −0.92% · $8.70
  4. T+20 · 3mo ago −6.46%α −9.73% · $8.11
  5. T+60 · 7w ago +6.69%α +4.20% · $9.25
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Xeris Biopharma insiders (C-suite/top officers) sold a total of ~$1.0M in stock over a 7-day window ending July 6, 2026, including a $723K sale by the CEO. The selling occurred near $8.03-$8.50, just off the stock's recent highs. While the dollar amount is modest relative to the $1.4B market cap (~0.07%), the cluster includes the CEO's largest single sale in the cluster and coincides with recent positive insider selling patterns (4 sales totaling $1.2M in the prior 30 days). No 10b5-1 pattern is evident from the data provided, and the cluster lacks an offsetting buy direction.

Key Financial Metrics

Direction
selling
Total Value
$1.0M
Insiders
3

Key Facts

  • Three insiders sold a total of ~$1.0M in stock between June 29 and July 6, 2026
  • CEO Kevin McCulloch sold 90,000 shares for ~$723K, the largest single trade in the cluster
  • Hecht Beth (See Remarks) sold 16,700 shares at $8.03 for ~$134K
  • Pieper Steven (See Remarks) sold 17,400 shares at $8.50 for ~$148K
  • Total insider cluster value is ~$1.0M, or ~0.07% of the $1.4B market cap
  • All three trades were open-market sales (code S); no buy transactions in the window
  • Prior 30-day insider activity at XERS shows 4 additional sales totaling $1.2M

Financial Impact

Selling of ~$1.0M by three insiders, representing ~0.07% of market cap

dilutioninsider ownership

Risk Factors

  • Risk of a secondary offering if the company is capitalizing on the stock's recent strength
  • CEOs selling a substantial portion of their holdings can signal limited upside confidence near current levels
  • High proportion of bullish analyst consensus (85% Strong Buy/Buy) could amplify negative sentiment if selling is interpreted as insiders disagreeing with Street optimism

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-XERS-1783491272602

US Market Status

Market Closed · Opens in 5h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 8, 2026